The influence of prescription monitoring programs on chronic pain management

Pain Physician

Volumn 12, Issue 3, 2009, Pages 507-515

  Wang, Jing ^a   Christo, Paul J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug abuse; Government Accountability Office; Health Insurance Portability and Accountability Act; National All Schedules Prescription Electronic Reporting Act; Prescription monitoring programs

Indexed keywords

CHRONIC PAIN; DATA BASE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG TRAFFIC; FUNDING; GENERAL PRACTICE; GOVERNMENT; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LAW; LAW ENFORCEMENT; PATIENT CARE; PATIENT MONITORING; PHARMACIST; PHYSICIAN; PRESCRIPTION; REVIEW; SUBSTANCE ABUSE; ARTICLE; DRUG CONTROL; INFORMATION PROCESSING; INTRACTABLE PAIN; OPIATE ADDICTION; ORGANIZATION AND MANAGEMENT; STANDARD; STATISTICS;

NARCOTIC AGENT;

DATA COLLECTION; DATABASES AS TOPIC; DRUG AND NARCOTIC CONTROL; DRUG MONITORING; DRUG PRESCRIPTIONS; HUMANS; NARCOTICS; OPIOID-RELATED DISORDERS; PAIN, INTRACTABLE;

EID: 69849098823     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Manchikanti L. National drug control policy and prescription drug abuse: Facts and fallacies. Pain Physician 2007; 10:399-424. (Pubitemid 46971294)
2. Manchikanti L. Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician 2006; 9:287-321. (Pubitemid 44717789)
3. Kuehn BM. Opioid prescriptions soar: Increase in legitimate use as well as abuse. JAMA 2007; 297:249-251.
4. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11: S63-S88. (Pubitemid 351682079)
5. Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment of pain and drug abuse and diversion. Pain Physician 2005; 8:335-347. (Pubitemid 41671947)
6. Trescot AM, Helm S, Hansen H, Benyamin RM, Glaser SE. Adlaka R, Patel S, Manchikanti L. Opioids in the Management of Chronic Non-Cancer Pain: An Update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11;S5-S62. (Pubitemid 351682078)
7. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349:1943-1953.
8. Ballantyne JC. Opioid analgesia: Perspectives on right use and utility. Pain Physician 2007; 10:479-491.
9. Substance Abuse and Mental Health Services Administration (2007). Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293. Rockville, MD. www.oas.samhsa.gov/nsduh/2k6nsduh/2k6results.pdf
10. Substance Abuse and Mental Health Services Administration (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings.Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194. Rockville, MD. www.oas.samhsa.gov/nsduh/2k5nsduh/2k5Results.pdf
11. Substance Abuse and Mental Health Services Administration (2005). Overview of Findings from the 2004 National Survey on Drug Use and Health. Office of Applied Studies, NSDUH Series H-27, DHHS Publication No. SMA 05-4061. Rockville, MD. www.oas.samhsa.govNSDUH/2k4NSDUH/2k4Overview.pdf
12. Substance Abuse and Mental Health Services Administration (2004). Overview of Findings from the 2003 National Survey on Drug Use and Health. Office of Applied Studies, NSDUH Series H-24, DHHS Publication No. SMA04-3963. Rockville, MD. www.oas.samhsa.gov/NHSDA/2k3N SDUH/2k3OverviewW.pdf
13. Substance Abuse and Mental Health Services Administration (2003). Overview of Findings from the 2002 National Survey on Drug Use and Health. Office of Applied Studies, NSDUH Series H-21, DHHS Publication No. SMA 03-3774. Rockville, MD. www.oas.samhsa.gov/N HSDA/2k2N SDUH/2k2SoFOverviewW.pdf
14. Substance Abuse and Mental Health Services Administration (2002). Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Office of Applied Studies, NHSDA Series H-17, DHHS Publication No. SMA 02-3758. Rockville, MD. www.oas.samhsa.gov/nhsda/2k1nhsda/ PDF/cover.pdf
15. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-29, DHHS Publication No. (SMA) 07-4256, Rockville, MD, March 2007. dawninfo.samhsa.gov/pubs/edpubs/default.asp
16. Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits DAWN Series D-28, DHHS Publication No. (SMA) 06-4143, Rockville, MD, April 2006. dawninfo.samhsa.gov/pubs/edpubs/default.asp
17. Drug Abuse Warning Network, 2003: Interim National Estimates of Drug-related Emergency Department Visits DAWN Series D-26, DHHS Publication No. (SMA) 04-3972, Rockville, MD, December 2004. dawninfo.samhsa.gov/pubs/edpubs/ default.asp
18. US Department of Health and Human Services. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network. The DAWN Report. Narcotic analgesics, 2002 update. September 2004.
19. US Department of Health and Human Services. Office of Applied Studies, Substance Abuse, and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network. The DAWN Report. Benzodiazepines in drug abuse-related emergency department visits, 1995-2002. April 2004.
20. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15:618-627. (Pubitemid 44404658)
21. Paulozzi L. Unintentional poisoning deaths - United States, 1999 - 2004. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2007; 56:93-96. www.cdc.gov/mmwr/preview/mmwrhtml/mm5605a1.htm
22. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies. Methadone-Associated Mortality: Report of a National Assessment. dpt. samhsa.gov/reports/index.htm.
23. Fingerhut LA. Increases in methadone related deaths: 1999-2004. Health EStats. Hyattsville, MD: National Center for Health Statistics; 2006. www.cdc.gov/nchs/products/pubs/pubd/hestats/methadone1999-04/methadone1999-04. htm
24. Centers for Disease Control and Prevention (CDC). Unintentional and undetermined poisoning deaths - 11 states, 1990 - 2001. MMWR Morb Mortal Wkly Rep 2004; 53:233-238.
25. Hughes AA, Bogdan GM, Dart RC. Active surveillance of abused and misused prescription opioids using poison center data: A pilot study and descriptive comparison. Clin Toxicol (Phila) 2007; 45:144-151.
26. Methadone Mortality Working Group Drug Enforcement Administration, Office of Diversion Control, April 2007.
27. US Department of Health and Human Services. Substance Abuse and Mental Health Services Administration (SAMHSA). Background Information for Methadone Mortality - A Reassessment. Sponsored by the Center for Substance Abuse Treatment, Substance Abuse, and Mental Health Services Administration. Washington, DC. July 20, 2007.
28. GAO Report. United States General Accounting Office. Prescription Drugs. OxyContin Abuse and Diversion and Efforts to Address the Problem. GAO Publication No. GAO-4-110, December 2003.
29. Martell BA, O'Connor PG, Kerns RD, Beck WC, Morales KH, Kosten TR, Fiellen DA. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146:116-127. (Pubitemid 351640015)
30. Manchikanti L, Damron KS, McManus CD, Barnhill RC. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician 2004; 7:431-437. (Pubitemid 39562100)
31. Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC, Fellows B. Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J KY Med Assoc 2003; 101:511-517.
32. Manchikanti L, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: An evaluation of patterns and trends. J Ky Med Assoc 2005; 103:55-62.
33. Manchikanti L, Damron KS, Beyer CD, Pampati V. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management. Pain Physician 2003; 6:281-285. (Pubitemid 36974922)
34. Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician 2003; 6:173-178. (Pubitemid 36974909)
35. Manchikanti L, Manchukonda R, Pampati V, Damron KS, Brandon DE, Cash KA, McManus CD. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006; 9:123-129.
36. Vaglienti RM, Huber SJ, Noel KR, Johnstone RE. Misuse of prescribed controlled substances defined by urinalysis. W V Med J 2003; 99:67-70.
37. Katz NP, Sherburne S, Beach M, Rose RJ, Vielguth J, Bradley J, Fanciullo GJ. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003; 97:1097-1102. (Pubitemid 37158696)
38. Michna E, Jamison RN, Pham LD, Ross EL, Nedeljkovic SS, Narang S, Palombi D, Wasan AD. Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings. Clin J Pain 2007; 23:173-179. (Pubitemid 46145464)
39. Manchikanti L, Damron KS, Pampati V, McManus CD, Weaver SE. Prospective evaluation of patients with increasing opiate needs: Prescription opiate abuse and illicit drug use. Pain Physician 2004; 7:339-344. (Pubitemid 39206372)
40. Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Pain Physician 2006; 9:215-226. (Pubitemid 44227394)
41. Manchikanti L, Giordano J, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manage 2007; 3:89-100. (Pubitemid 46760149)
42. Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, Shilliday BB, DeWalt DA, Pignone MP. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006; 6:46.
43. Manchikanti L, Manchukonda R, Pampati V, Damron KS. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician 2005; 8:257-261. (Pubitemid 41131536)
44. Manchikanti L, Pampati V, Damron KS, McManus CD. Evaluation of variables in illicit drug use: Does a controlled substance abuse screening tool identify illicit drug use? Pain Physician 2004; 7:71-75. (Pubitemid 38195756)
45. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash KA. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006; 9:57-60. (Pubitemid 43263665)
46. Kell M. Monitoring compliance with OxyContin prescriptions in 14,712 patients treated in 127 outpatient pain centers. Pain Med 2005; 6:186-187.
47. Atluri S, Sudarshan G. Evaluation of abnormal urine drug screens among patients with chronic non-malignant pain treated with opioids. Pain Physician 2003; 6:407-409. (Pubitemid 37455825)
48. Bollinger LC BC, Califano JA, Chenault KI, Curtis JL, Dimon J, Dolan PR, Ganzi VF, Fisher M, Kelmenson LA, Keough DR, Kessler DA, Malloy EA, Pacheco MT, Plumeri II JJ, Redstone SE, Rosenwald Jr EJ, Schulhof MP, Sullivan LW, Sweeney JJ, Wiener MA. Under the counter. The diversion and abuse of controlled prescription drugs in the U.S. The National Center on Addiction and Substance Abuse at Columbia University (CASA), July 2005.
49. Friedman RA. The changing face of teenage drug abuse - the trend toward prescription drugs. N Engl J Med 2006; 354:1448-1450.
50. Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) guidelines. Pain Physician 2008; 11:S5-S62. (Pubitemid 351682078)
51. Boswell MV, Trescot AM, Datta S, Schultz DM, Hansen HC, Abdi S, Sehgal N, Shah RV, Singh V, Benyamin RM, Patel VB, Buenaventura RM, Colson JD, Cordner HJ, Epter RS, Jasper JF, Dunbar EE, Atluri SL, Bowman RC, Deer TR, Swicegood JR, Staats PS, Smith HS, Burton AW, Kloth DS, Giordano J, Manchikanti L. Interventional techniques: Evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 2007; 10:7-111. (Pubitemid 46290965)
52. Cleeland CS. Undertreatment of cancer pain in elderly patients. JAMA 1998; 279:1914-1915. (Pubitemid 28299290)
53. Breitbart W, Rosenfeld BD, Passik SD, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain 1996; 65:243-249. (Pubitemid 26228041)
54. Zenz M, Zenz T, Tryba M, Strumpf M. Severe undertreatment of cancer pain: A 3-year survey of the German situation. J Pain Symptom Manage 1995; 10:187-191.
55. Tunca M, Yelken J. Undertreatment of cancer pain. Lancet 1991; 337:1294.
56. Pasero C, McCaffery M. The undertreatment of pain. Am J Nurs 2001; 101:62-65.
57. Frank-Stromborg M, Christiansen A. The undertreatment of pain: A liability risk for nurses. Clin J Oncol Nurs 2000; 4:41-44.
58. Schechter NL. The undertreatment of pain in children: An overview. Pediatr Clin North Am 1989; 36:781-794.
59. Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: Multicentre study. BMJ 1997; 314:23-28. (Pubitemid 27023232)
60. Ballantyne JC. Chronic pain following treatment for cancer: The role of opioids. Oncologist 2003; 8:567-575. (Pubitemid 37467372)
61. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112:372-380. (Pubitemid 39550738)
62. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006; 174:1589-1594. (Pubitemid 43829515)
63. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: A systematic review. J Pain Symptom Manage 2003; 26:1026-1048. (Pubitemid 37324684)
64. Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil 2005; 84:S42-S55.
65. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain 2006; 125:172-179. (Pubitemid 44498976)
66. Federation of State Medical Boards of the United States, Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. May 2004. www.fsmb.org/pdf/2004-grpol-Controlled-Substances.pdf
67. Bennett DS, Simon S, Brennan M, Shoemaker SA. Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics. J Opioid Manage 2007; 3:101-106. (Pubitemid 46760150)
68. Davstad I, Stenbacka M, Leifman A, Beck O, Korkmaz S, Romelsjo A. Patterns of illicit drug use and retention in a methadone program: A longitudinal study. J Opioid Manag 2007; 3:27-34. (Pubitemid 350199791)
69. Havens JR, Oser CB, Leukefeld CG. Increasing prevalence of prescription opiate misuse over time among rural probationers. J Opioid Manage 2007; 3:107-112.
70. Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery, and late opioid use. Spine 2007; 32:2127-2132.
71. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence task force on prescription opioid non-medical use and abuse (position statement). Drug Alcohol Depend 2003; 69:215-232. (Pubitemid 36293934)
72. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004; 109:514-519.
73. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: Impact on health care costs and service use. Spine 2005; 30:1075-1081. (Pubitemid 40663916)
74. Mahmud MA, Webster BS, Courtney TK, Matz S, Tacci JA, Christiani DC. Clinical management and the duration of disability for work-related low back pain. J Occup Environ Med 2000; 42:1178-1187. (Pubitemid 32014681)
75. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum 2005; 52:312-321. (Pubitemid 40129264)
76. Fanciullo GJ, Ball PA, Girault G, Rose RJ, Hanscom B, Weinstein JN. An observational study on the prevalence and pattern of opioid use in 25,479 patients with spine and radicular pain. Spine 2002; 27:201-205. (Pubitemid 34215562)
77. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 2003; 28:143-150. (Pubitemid 36110081)
78. Deyo RA, Bass JE, Walsh NE, Schoenfeld LS, Ramamurthy S. Prognostic variability among chronic pain patients: Implications for study design, interpretation, and reporting. Arch Phys Med Rehabil 1988; 69:174-178. (Pubitemid 18091459)
79. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain 2003; 4:344-350. (Pubitemid 37013026)
80. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic non-cancer pain syndromes in primary care. J Gen Intern Med 2002; 17:173-179. (Pubitemid 34603843)
81. Bramley-Moore SR, Wodak AD, Day RO, Lauchlan RL. Patterns of analgesic prescribing for patients with chronic non-malignant pain in NSW. Aust J Hosp Pharm 1998; 28:83-88. (Pubitemid 28221723)
82. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 2007; 8:573-584.
83. Office of Applied Studies (2007). Changes in Prevalence Rates of Drug Use between 2002-2003 and 2004-2005 among states. Rockville, MD: Substance Abuse and Mental Health Administration. www.oas.samhsa.gov/StateChanges/3trends.doc
84. Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine 2004; 29:884-891. (Pubitemid 38480972)
85. GAO Report. GAO-02-634 Prescription drugs. State monitoring programs provide useful tool to reduce diversion. May 2002.
86. Harold Rogers Prescription Drug Monitoring Program. U.S. Department of Justice. www/ojp.usdoj.gov/BJA/grant/prescriptiondrugs.html
87. Public law No: 109-160 H.R.1132 signed by President George W. Bush on 8/11/05. http://thomas.loc.gov/bss/d109/d109laws.html
88. Twillman RK. Report from the 10th World Congress on Pain. J Pain Palliat Care Pharmacother 2003; 17:83-88. (Pubitemid 36988100)
89. Twillman R. Impact of prescription monitoring programs on prescription patterns and indicators of opioid abuse. J Pain 2006; 7:S6.
90. Popenhagen MP. Collaborative practice. Undertreatment of pain and fears of addiction in pediatric chronic pain patients: How do we stop the problem? J Spec Pediatr Nurs 2006; 11:61-67.
91. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008; Jul 15.
92. Resnik DB, Rehm M, Minard RB. The undertreatment of pain: Scientific, clinical, cultural, and philosophical factors. Med Health Care Philos 2001; 4:277-288.
93. Conn J. HIPAA, 10 years after. Mod Healthc 2006; 36:26-28.
94. HIPAA general overview. Part II. Ohio Nurses Rev 2003; 78:10, 13.
95. HIPAA general overview. Part I. Ohio Nurses Rev 2003;78:14.
96. HIPAA and Public Health. WV Med J 2004; 100:244.
97. Simeone R, Holland L. An evaluation of prescription monitoring programs. September 1, 2006. www.ojp.usdoj.gov/BJA/pdf/PDMPExecSumm.pdf
98. Katz N, Houle B, Fernandez KC, Kreiner P, Thomas CP, Kim M, Carrow GM, Audet A, Brushwood D. Update on prescription monitoring in clinical practice: A survey study of prescription monitoring program administrators. Pain Med 2008; 9:587-594.